Fighting heart disease across borders - announcing a €12 million partnership with German scientists

12 February 2018        

Category: Research

Today we announced we will be investing in a €12 million partnership with the German Centre for Cardiovascular Research (DZHK), to fund ground-breaking research and foster international collaboration. 

Every year we fund around £100 million of cardiovascular research, which makes us one of the largest independent funders in Europe. The DZHK is a major multi-centre enterprise for cardiovascular research in Germany. The award scheme will fund research projects across international borders, and work to tackle new and globally important questions in heart and circulatory disease. 

In this partnership, we will focus on projects that will improve diagnosis, prevention or treatment covering a wide range of disciplines, from biochemistry and medicine to data science and artificial intelligence. 

Jeremy Pearson our Associate Medical Director described the importance of the partnership

“Many of the researchers we fund already work with scientists right across Europe. At a time when our relationship with the EU is being redefined, it’s critical that we have a clear vision of how we’ll continue to foster this kind of collaborative environment. That is what makes this such an exciting partnership.

“The scientists funded by the BHF and the DZHK carry out world-class research and have a shared vision of beating cardiovascular disease. By enabling them to combine their expertise, we want to elevate both the scope and impact of the research discoveries that arise to a whole new level and ultimately improve the way we can diagnose and treat heart patients.”

Professor Thomas Eschenhagen, Chairman of the DZHK also welcomed the partnership

“We are very excited by this new joint funding scheme. It is an excellent opportunity to strengthen the firm ties between British and German cardiovascular scientists in times of centrifugal forces and do things we couldn't do at the respective national level. It is a signal that science reaches beyond national borders – as does cardiovascular disease. We need new ways to fight cardiovascular disease and believe that the BHF/DZHK funding scheme could make a difference.”

Read our blog about the importance of international collaboration